The need for GLP-1 receptor agonists is rapidly rising due to the increasing prevalence of type 2 diabetes and obesity worldwide
This has practical implications: Cost sustainability: Can you afford treatment indefinitely
Instructions for Use - 0.25 mg or 0.5 mg doses, 2 mg/3 mL pen Mechanism of Action Semaglutide is a GLP-1 analogue with 94% sequence homology to human GLP-1
What makes the process work is clear communication, a stable dose going in, and a realistic plan for nutrition and hydration during stimulation
Compounded semaglutide was previously another option, but the FDA told manufacturers to shut down production in February 2025
In some cases, people will adjust to the side effects and when you skip the week, sometimes the side effects come back, Seltzer says